Hepion director Liddy Gordon reports no share holdings
Hepion Pharmaceuticals, Inc. (HEPA) reported an initial statement of beneficial ownership for director Liddy James Gordon on a Form 3.
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. (HEPA) reported an initial statement of beneficial ownership for director Liddy James Gordon on a Form 3. The filing lists no equity transactions, derivative positions, or specific share holdings for this reporting person at the time of filing.
Positive
- None.
Negative
- None.
Key Terms
beneficial ownership, reporting person, ten percent owner, Rule 10b5-1
4 terms
beneficial ownership financial
"reported an initial statement of beneficial ownership for director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
reporting person regulatory
"identifies Liddy James Gordon as a director and initial reporting person"
ten percent owner regulatory
"indicates that the reporting person is not a ten percent owner"
Rule 10b5-1 regulatory
"no specific reference to trades made under a Rule 10b5-1 plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What does the HEPA Form 3 filed for Liddy James Gordon disclose?
The Form 3 for Hepion Pharmaceuticals, Inc. (HEPA) identifies Liddy James Gordon as a director and initial reporting person. It shows no reported transactions, derivative positions, or specific share holdings at the time of the filing.
Are there any buy or sell transactions reported in this HEPA Form 3?
No. The insider data show zero buy, sell, acquire, dispose, or other transactions for Liddy James Gordon in this Form 3 for Hepion Pharmaceuticals, Inc.
Is Liddy James Gordon a ten percent owner of HEPA according to this Form 3?
No. The Form 3 lists Liddy James Gordon as a director of Hepion Pharmaceuticals, Inc. (HEPA) and indicates that the reporting person is not a ten percent owner.
Does the HEPA Form 3 mention any Rule 10b5-1 trading plan for Liddy James Gordon?
No. The Form 3 insider data show the Rule 10b5-1 trading plan indicator as null, with no transactions reported and no specific reference to trades made under a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
